Infectious Diseases News and Research

RSS

Drug-resistant gonorrhea is a major public health concern

The increasing resistance to fluoroquinolones effectively eliminates an entire class of antibiotics and leaves only one class of drugs -- cephalosporins -- as the first-line therapy in the treatment of gonorrhea. There are currently no other major groups of antibiotics left to treat gonorrhea.

2 May 2004

Immunization back on agenda as whooping cough increases

Immunization for pertussis, also known as whooping cough, began in the mid-1940s and resulted in a sharp decline of this serious illness over the next 25 years. Over the last two decades, however, as immunity has waned, pertussis has re-emerged in the United States, with the greatest increase seen in adolescents, adults and young infants.

1 May 2004

HIV test after wrong woman's breast milk given to baby

An Australian hospital has been forced to test a baby for HIV, hepatitis and other infectious diseases after she was given the wrong woman's breast milk.

1 May 2004

New technique of identifying genes may help researchers developing drugs

A quick new technique able to identify genes that evolve rapidly as well as those that change slowly already has pinpointed new targets for researchers developing drugs against tuberculosis and malaria, and it could do the same for other infectious diseases, according to a paper in this week's Nature.

29 Apr 2004

Having pets helps protect infants against allergies

Having siblings, keeping a pet, or living on a farm helps protect infants against the development of atopic (allergic) diseases, but early infections increase the risk, according to new research from Denmark. This study will be available on bmj.com on Friday 30 May 2004.

29 Apr 2004

Canada kicks off National Immunization Awareness Week

Marking National Immunization Awareness Week, Canada's health ministers today encouraged parents and care givers across the country to have their children immunized.

28 Apr 2004

Scientists looking for 480 people to test experimental anthrax vaccine

Scientists in Rochester and 11 other cities around the nation are beginning tests of an experimental vaccine aimed at protecting people against anthrax, a rare disease that, like smallpox, has become more threatening with the emergence of bioterrorism.

28 Apr 2004

Experimental smallpox DNA vaccine

In the first successful study of its kind, scientists have shown that a DNA-based vaccine for smallpox can protect nonhuman primates from monkeypox, a disease that resembles smallpox in humans.

27 Apr 2004

Experimental immune-boosting drug interleukin-2 helps HIV Patients

National Institutes of Health (NIH) scientists report that brief, widely-spaced courses of the experimental immune-boosting drug interleukin-2 (IL-2) allow people with HIV to maintain near normal levels of a key immune system cell for long periods.

26 Apr 2004

SARS antibody sent to China

Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.

26 Apr 2004

Severe Acute Respiratory Syndrome (SARS) overview

Severe Acute Respiratory Syndrome (SARS) is an atypical form of pneumonia that first appeared in November 2002 in Guangdong Province, China.

24 Apr 2004

CellCept linked to reduced cancer incidence

A study presented today at an international transplant meeting showed that heart transplant patients treated with the immunosuppressant CellCeptÒ (mycophenolate mofetil) in standard immunosuppressive regimens had a significantly lower risk of developing cancer compared to those receiving non-CellCept-based treatment regimens.

23 Apr 2004

GSK and WHO collaborate to fight malaria

GlaxoSmithKline (GSK), the World Health Organisation's Special Programme for Research and Training in Tropical Diseases (WHO-TDR) and the Medicines for Malaria Venture (MMV) today announced the signing of a collaborative agreement, to develop a new-fixed dose artemisinin combination therapy drug (ACT), combining chlorproguanil, dapsone and artesunate (CDA) for the treatment of malaria.

23 Apr 2004

Research into link between oceans and human health

The National Science Foundation (NSF) and the National Institute of Environmental Health Sciences (NIEHS), one of the National Institutes of Health, have announced funding for four joint Centers for Oceans and Human Health (COHH). The centers will be located at the University of Washington, the University of Hawaii, the Woods Hole Oceanographic Institution in Massachusetts, and the University of Miami.

22 Apr 2004

Surviving pneumonia may only provide a short-term lease on a future healthy life

Researchers have shown that the subsequent 2 to 3 years after discharge from the hospital following treatment for pneumonia may provide only a short-term lease on a future healthy life if the patient has certain significant and independent predictors of mortality.

20 Apr 2004

Can public health promotion beat disease?

Huge efforts are under way to address health problems such as SARS, HIV, diabetes and many other illnesses by developing vaccines or therapeutic drugs.

20 Apr 2004

Pfizer donates £1 million Brighton and Sussex Medical School

Brighton and Sussex Medical School (BSMS) is pleased to announce that it has received a £1 million donation from pharmaceutical company, Pfizer (UK).

20 Apr 2004

44 countries to hammer out global health issues at Earth Observation Summit

44 countries will hammer out plans for sharing outbreak data at the Earth Observation Summit meeting, to be held Sunday in Tokyo.

19 Apr 2004

Jefferson scientists learn how HIV causes dementia

Ever since the AIDS epidemic began more than two decades ago, scientists have been trying to understand why as many as one-quarter of those infected with HIV develop dementia.

19 Apr 2004

World expert speaks on bioterrorism and emerging infections

World renowned and esteemed Australian virologist Professor Frank Fenner will present the inaugural Rod Andrew Oration this week at Monash University. His topic "Big lessons from smallpox: bioterrorism and emerging infections" is timely and sure to be thought-provoking.

19 Apr 2004